Avancerad sökning
Visar resultat 1 - 5 av 6 avhandlingar som matchar ovanstående sökkriterier.
1. Computer Simulation of the Neural Control of Locomotion in the Cat and the Salamander
Sammanfattning : Locomotion is an integral part of a whole range of animal behaviours. The basic rhythm for locomotion in vertebrates has been shown to arise from local networks residing in the spinal cord and these networks are known as central pattern generators (CPG). LÄS MER
2. Human motion prediction using wearable sensors and machine Learning
Sammanfattning : Accurately measuring and predicting human movement is important in many contexts, such as in rehabilitation and the design of assistive devices. Thanks to the development and availability of a wide variety of sensors, scientists study human movement in many settings and capture characteristic properties unique to individuals as well as to larger study populations. LÄS MER
3. Vägen till vinnarcirkeln. Travhästen och dess människor mellan sport och spel
Sammanfattning : The way we understand and treat our horses, like the purpose for which they are bred, is culturally conditioned. The transition between differing social formations involves not only new life circumstances for people and animals, but also changed social modes of relating between them. LÄS MER
4. Facilitating Exoskeletons in Daily Use : Simulations and Predictions for Design and Control
Sammanfattning : Lower limb exoskeletons have been extensively developed over the last several decades for people with and without movement disorders. Although lower limb exoskeletons have been shown to provide effective assistance to improve gait and reduce metabolic cost during movements, they are often heavy, bulky and uncomfortable. LÄS MER
5. Studies of the Biology of Intrathecal Treatment in Progressive MS
Sammanfattning : Background: Multiple Sclerosis (MS) is a chronic, inflammatory, autoimmune disease, affecting the central nervous system (CNS). About 85% of afflicted present with a relapsing-remitting form of the disease (RRMS), for which a breakthrough in treatment was made in 2008 with rituximab, an antibody directed towards CD20, a surface antigen on B-cells. LÄS MER